Patents by Inventor Caridad Rosette

Caridad Rosette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AN IN-SITU GELLING ENEMA OF RIFAMYCIN FOR TREATING POUCHITIS AND DISTAL ULCERATIVE COLITIS
    Publication number: 20240408008
    Abstract: The present disclosure relates to an (in situ gelling) enema containing Rifamycin SV and its use in the treatment of pouchitis, proctitis and/or distal ulcerative colitis (including proctosigmoiditis). More particularly, the present disclosure describes an in situ gelling retentive enema containing Rifamycin SV for treating, ameliorating, reducing the severity of or slowing the progression of pouchitis, proctitis and/or distal ulcerative colitis (including proctosigmoiditis).
    Type: Application
    Filed: October 5, 2022
    Publication date: December 12, 2024
    Applicant: COSMO TECHNOLOGIES LTD.
    Inventors: Mara GERLONI, Cristina MACELLONI, Caridad ROSETTE, Luigi LONGO
  • METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
    Publication number: 20090258344
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: October 15, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Andreas Braun, Stefan M. Kammerer, Mikhail F. Denissenko, Rikard Reneland, Caridad Rosette, Carolyn R. Hoyal-Wrightson
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050118606
    Abstract: Provided herein are methods for identifying a risk of cancer in a subject and/or a subject at risk of cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating cancer, and therapeutic methods for treating cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in a KLF12 nucleic acid, which has a nucleotide sequence exemplified in SEQ ID NO: 1, 2 or 3.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 2, 2005
    Inventors: Richard Roth, Caridad Rosette, Mikhail Denissenko, Matthew Nelson, Rikard Reneland, Andreas Braun, Stefan Kammerer